Author

Patrick Vermersch

InsermORCID 0000-0003-0997-8817Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

Alain Moussy· 2 shared Colin D. MansfieldiD· 2 shared Olivier HermineiD· 2 shared Kathleen Flosseau· 1 shared Lamya Loussaief· 1 shared Laurent GrosiD· 1 shared Truong-An Tran· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Alain Moussy

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintJul 7, 2026

Masitinib is an oral, brain penetrant inhibitor of microglial and mast cell activity with neuroprotective potential in progressive forms of multiple sclerosis

Patrick Vermersch, Alain Moussy, Colin D. Mansfield, Olivier Hermine

This paper demonstrates that masitinib achieves sufficient CNS concentrations to inhibit key targets in progressive MS, showing neuroprotective effects and potential as a treatment.

DOI 10.64898/2026.07.02.735783

ratexperimental assay

𝕏 PostBluesky

NeurosciencePLoS ONEPeer-reviewedMay 14, 2025

Masitinib Limits Neuronal Damage, as Measured by Serum Neurofilament Light Chain Concentration, in a Model of Neuroimmune-Driven Neurodegenerative Disease

Olivier Hermine, Laurent Gros, Truong-An Tran…·Patrick Vermersch

2 citations

mousestatistical model

𝕏 PostBluesky